521 rows · 7 boards

The Cross-Board Pricing Index

Every provider we track, for every compound it sells, in one table: 203 providers across 7 boards (Tirzepatide, Sermorelin, Semaglutide, NAD+, Glutathione, PT-141, GHK-Cu), 521 priced rows total. Nothing here is a new number — every price is the board's own already-verified figure, unmodified, sorted cheapest first.

160 of 521 rows name a specific FDA regulatory category for the pharmacy that fills the prescription; the rest are marked “Not disclosed” or “Unverified” rather than assumed. Verification dates on this page range from August 2026 to September 2026. Prices may change — verify the current number on the provider's own site before you buy. Filter the table below by compound, pharmacy disclosure, partner status, or published state coverage — every combination composes. Prefer a card-by-card view instead of a raw table?